Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients.
Relapsing-Remitting multiple sclerosis
fear
psychometric properties
relapse
scale development
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
07
2019
accepted:
09
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
4
2020
Statut:
epublish
Résumé
Chronic diseases are associated with patients' long-term stress and development of fear to things related to the source of stress. Better management of a patients' condition requires investigation of the underlying mechanisms that contribute to the process of development of chronic stress. Multiple Sclerosis (MS) is a debilitating chronic disease in most cases diagnosed after a relapse and characterized by the periodic occurrence of relapses in most patients. Due to the unpredictable course of the disease and relapses, patients with Relapsing-Remitting MS (RRMS) may deal with the stress of anticipation of relapse and its unpredictable consequences. The role of relapses and related stress on patients' quality of life has not been previously investigated. This study is the first effort to develop a self-report measure of Fear of Relapse (FoR) in patients with RRMS. Thirty-one items were extracted from in-depth clinical interviews with 33 RRMS patients to develop the preliminary version of the scale. Subsequently, 168 RRMS patients completed the questionnaire, the Intolerance of Uncertainty Scale (IUS) and Depression, Anxiety, and Stress Scale (DASS). Fifty-one patients completed the scale one more time a month later. Factor analysis revealed three components, and five items failed to load on any of them. To test the FoR's independence from similar measures, responses to 26 items were pooled once with DASS items and once with IUS items, and each time were subjected to confirmatory factor analysis (two-component solution). Despite significant correlations between FoR, DASS, and IUS Independent loadings of items belonging to FoR and DASS, and FoR and IUS revealed independence and unique contribution of FoR to the evaluation of patients. Cronbach's alpha for the 26-item version was 0.92. Test-retest reliability for total score was equal to 0.74. These findings provide preliminary evidence of the validity and reliability of the measure. This scale can help researchers and clinicians to have a more comprehensive understanding of patients' experience with the uncertain nature of MS, which is necessary for future efforts to address this stressor by targeting the underlying mechanism.
Identifiants
pubmed: 32265764
doi: 10.3389/fpsyt.2020.00226
pmc: PMC7100001
doi:
Types de publication
Journal Article
Langues
eng
Pagination
226Informations de copyright
Copyright © 2020 Khatibi, Moradi, Rahbari, Salehi and Dehghani.
Références
Psychother Psychosom. 2018;87(3):190-192
pubmed: 29533948
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
Psychol Rep. 1995 Apr;76(2):515-21
pubmed: 7667463
Health Psychol Res. 2013 Sep 23;1(3):e27
pubmed: 26973912
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
Mult Scler. 2007 Nov;13(9):1168-75
pubmed: 17881391
Psychol Med. 2014 Jan;44(2):349-59
pubmed: 23680407
J Psychosom Res. 2005 Jun;58(6):505-11
pubmed: 16125517
Health Psychol. 1997 Mar;16(2):171-4
pubmed: 9269888
Psychol Health Med. 2017 Oct;22(9):1063-1071
pubmed: 28058855
Pain. 1999 Mar;80(1-2):329-39
pubmed: 10204746
Qual Life Res. 2013 Oct;22(8):1943-54
pubmed: 23247892
Health Psychol Open. 2015 Nov 4;2(2):2055102915612271
pubmed: 28070374
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
Behav Res Ther. 2002 Aug;40(8):931-45
pubmed: 12186356
Front Psychol. 2018 May 23;9:786
pubmed: 29875723
Am J Psychiatry. 1988 Aug;145(8):976-81
pubmed: 2969199
Med Care. 1999 Jan;37(1):5-14
pubmed: 10413387
Disabil Health J. 2018 Oct;11(4):555-561
pubmed: 29891186
Basic Clin Neurosci. 2017 Nov-Dec;8(6):467-478
pubmed: 29942430
Arch Neurol. 2006 Dec;63(12):1686-91
pubmed: 17172607
Anxiety Stress Coping. 2007 Sep;20(3):253-65
pubmed: 17999228
Pain Res Manag. 2016;2016:6838596
pubmed: 27445620
Public Health Rep. 2004 May-Jun;119(3):239-43
pubmed: 15158102
Diabetes Metab J. 2017 Dec;41(6):449-456
pubmed: 29272083
Acta Neurol Scand. 2003 Dec;108(6):389-95
pubmed: 14616290